4//SEC Filing
Schaub James 4
Accession 0001104659-20-064436
CIK 0001739426other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 9:47 PM ET
Size
7.4 KB
Accession
0001104659-20-064436
Insider Transaction Report
Form 4
Schaub James
EVP and COO
Transactions
- Award
Ordinary Shares
2020-05-18+73,253→ 328,408 total - Award
Performance-Based Restricted Stock Units
2020-05-18+73,253→ 73,253 total→ Ordinary Shares (73,253 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units.
- [F2]The performance-based restricted stock units represent a contingent right to receive, upon vesting, a varying number of the registrant's ordinary shares based on certain pre-determined thresholds for the closing price of registrant's ordinary shares on the Nasdaq Global Select Market. The performance-based restricted stock units vest on the third anniversary of the date of grant and, upon vesting, will convert into 0%, 50%, 100% or 150% of the target number of ordinary shares listed in Column 7 of Table II.
Documents
Issuer
Osmotica Pharmaceuticals plc
CIK 0001739426
Entity typeother
Related Parties
1- filerCIK 0001752153
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 9:47 PM ET
- Size
- 7.4 KB